S-1/A: Know Labs Files Amendment No. 1 to Form S-1 for Resale of Common Stock

Know Labs has filed an amendment to its Form S-1 registration statement to allow a selling stockholder to resell up to 10,800,000 shares of common stock.

Summary

• Know Labs, Inc. has filed Amendment No. 1 to its Form S-1 registration statement with the SEC.
• The amendment primarily updates the Incorporation by Reference section and revises Item 16 regarding Exhibits.
• The prospectus relates to the resale of up to 4,800,000 shares of Common Stock issuable upon conversion of a secured, convertible note in the principal amount of $4,800,000 at an initial conversion price of $1.00 per share.
• It also covers up to 6,000,000 shares of Common Stock underlying a common stock purchase warrant at an initial exercise price of $0.80 per share.
• Know Labs will not receive any proceeds from the sale of shares by the selling stockholder.
• As of March 25, 2024, the closing price of Know Labs' common stock on the NYSE American was $0.65 per share.

Sentiment

Score: 5

Explanation: The document is neutral in sentiment as it primarily describes the details of a stock resale registration. It contains standard risk disclosures, but no overtly positive or negative statements about the company's future prospects.

Risks

• The prospectus highlights that investing in Know Labs' securities involves a high degree of risk.
• The selling stockholder may be deemed an underwriter, increasing potential liability.
• The company will not receive any proceeds from the sale of shares by the selling stockholder.
• The company's stock price is volatile, which may cause investment losses for stockholders.

Future Outlook

The selling stockholder may sell some, all, or none of the securities offered by this prospectus, and the company does not know when or in what amount the selling stockholder may offer the securities for sale.

Industry Context

Know Labs is positioning itself in the non-invasive medical diagnostics market, particularly in blood glucose monitoring, which is a competitive and rapidly evolving field.

Stakeholder Impact

• The resale of shares could potentially dilute existing shareholders' equity.
• The offering provides an opportunity for the selling stockholder to liquidate its investment.

Key Dates

Keywords

common stock, resale, convertible note, warrant, S-1, Know Labs, registration statement